Search

everythinglearnresearchcommunity

for

Search:↓

Some common medications can harm male fertility, but many effects can be reversed.

Laser/light treatments for hair loss are popular but lack scientific data proving effectiveness.

Finasteride helps reduce priapism in sickle cell anemia patients.

Topical JAK inhibitors may help treat alopecia universalis by promoting hair regrowth.

Some treatments can help with hair regrowth in alopecia areata, but results vary and long-term use is often needed without changing the disease's outcome.

Oral tofacitinib shows promise in treating atopic dermatitis and alopecia areata, but only slight improvement in vitiligo.

The document concludes that there are various treatments for different types of alopecia, but more research is needed for evidence-based treatments.

Baricitinib helped a woman with severe hair loss regrow almost all her hair without side effects.

The document describes a treatment for excessive hair growth in a teenage girl using medication and birth control, but does not report the results.

Early treatment helps stop hair loss in women of color.

Some herbal treatments are effective for skin disorders, but more research and regulation are needed.

The document concludes that treating androgen excess needs patience, managing expectations is important, and many drugs used are not officially approved, suggesting cosmetic options for mild cases.

The study identified the top 10 most important areas for future hair loss research.

Various treatments exist for alopecia areata, but none are completely satisfactory; choice depends on age, disease extent, and preference.

Treating epilepsy is complex, requiring careful drug choice and patient adherence to manage seizures and side effects.

Laser treatment and deroofing are effective options for hidradenitis suppurativa.

Tofacitinib may be safe for COVID-19 patients with alopecia without worsening symptoms, based on two cases.

The book concludes that treating acne scars requires a variety of methods and patience, with no single best way to classify or treat them.

Hormonal therapies are effective for managing hair and skin symptoms in women with PCOS.

The document concludes that effective acne treatment requires a personalized combination of therapies and long-term commitment, with retinoids being important for maintenance.

Troglitazone increases subcutaneous fat in lipodystrophy patients.

Alopecia areata treatment should be personalized, using topical or systemic therapies based on severity, with promising options like JAK inhibitors needing more research.

Calcipotriol may effectively treat hair loss in alopecia areata, working better in children than adults.

A protein combining parathyroid hormone and collagen helped hair regrow in mice with a hair loss condition.

Some plant-based treatments may help with ovary function, insulin resistance, and excess male hormones in PCOS, but more research is needed to confirm their safety and effectiveness.

The treatment improved hair growth and thickness in patients with hair loss, even 10 months after therapy without additional products.

Treatments for hair loss vary, but cell-based options may be the future.

The guideline recommends mental health involvement in diagnosing gender identity disorder and outlines hormone and surgical treatment protocols, emphasizing safety, informed consent, and long-term monitoring.

Future hair loss treatments should aim to extend hair growth, reactivate resting follicles, reverse shrinkage, and possibly create new follicles, with gene therapy showing promise.

PRP treatment helps hair growth and density in androgenetic alopecia patients.